Blockbuster Biologics Review, produced by our intellectual property lawyers, covers developments in inter partes review (IPR) and patent litigation challenges to blockbuster biologic drugs.
These quarterly reports provide updates on the following topics:
We will continue to monitor developments and provide updates regularly.
2024
2023
2022
2021
2020
For access to an issue prior to 2020, please contact IPPGBusinessDevelopmentLocal@morganlewis.com.
News
Thought Leadership